Investment Rating - The investment rating for the company is "Buy" with a market price of RMB 71.20 and a sector rating of "Outperform" [1] Core Views - The company is expected to turn profitable in 2024, driven by the success of its "subscription business" and "channel-first" dual transformation strategy [1][5] - The company reported a revenue of RMB 711 million in 2024, representing a year-on-year growth of 16.44%, and a net profit attributable to shareholders of RMB 27 million, marking a turnaround from losses [3][5] Financial Performance Summary - For 2024, the company achieved a revenue of RMB 711 million, with a growth rate of 16.4% compared to 2023 [7] - The net profit for 2024 was RMB 27 million, a significant recovery from a loss of RMB 91 million in 2023, indicating a growth rate of 5,114.8% [7] - The earnings per share (EPS) for 2024 is projected at RMB 0.29, with further increases expected in subsequent years [5][7] Subscription Business Growth - The company launched a new subscription plan in 2024, leading to an Annual Recurring Revenue (ARR) of RMB 411 million, which is a 64.42% increase year-on-year [8] - Subscription revenue accounted for 49.31% of total revenue in 2024, demonstrating the effectiveness of the subscription-first strategy [8] Channel Development - The company has made significant progress in channel development, particularly in the Asia-Pacific and Middle East regions, with revenue growth of 53.42% and 24.02% respectively [8] - Channel revenue for 2024 reached RMB 292 million, representing 41.05% of total revenue [8] Future Projections - Revenue projections for 2025, 2026, and 2027 are RMB 807 million, RMB 904 million, and RMB 1,008 million respectively, with corresponding net profits of RMB 45 million, RMB 65 million, and RMB 93 million [5][7] - The company is expected to maintain a strong growth trajectory with a focus on subscription and channel strategies [5][8]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance in the near term [1][5]. Core Views - The company has demonstrated high growth in performance, with strong progress in product research, validation, and ramp-up, leading to an optimistic outlook [1][5]. - The company reported a revenue of RMB 1.835 billion for 2024, representing a year-on-year increase of 48.24%, and a net profit of RMB 534 million, up 32.51% year-on-year [8][9]. - The report highlights the steady increase in market share for the company's polishing liquids, with a global market share rising from approximately 7% to 11% over the past three years [8]. Financial Performance Summary - For 2024, the company achieved a total revenue of RMB 1,835 million, with a growth rate of 48.24% compared to 2023 [9]. - The gross profit margin for 2024 was 58.45%, an increase of 2.64 percentage points year-on-year, while the net profit margin was 29.08%, a decrease of 3.45 percentage points [8]. - In Q1 2025, the company reported revenue of RMB 545.28 million, a year-on-year increase of 44.08%, and a net profit of RMB 168.83 million, up 60.66% year-on-year [11]. Market Position and Growth Prospects - The company’s polishing liquid revenue reached RMB 1.545 billion in 2024, with a year-on-year growth of 43.73% and a gross margin of 61.16% [8]. - The global semiconductor CMP polishing materials market is projected to grow from USD 3.42 billion in 2024 to USD 3.62 billion in 2025, with a compound annual growth rate (CAGR) of 5.6% from 2024 to 2028 [8]. - The company’s functional wet electronic chemicals segment saw revenue growth of 78.91% in 2024, indicating strong demand and market expansion [8].

支撑评级的要点 投资建议 评级面临的主要风险 ◼ 集采政策实施力度超预期的风险。企业研发不及预期风险。产品销售不及预期风险。 相关研究报告 《CXO 行业点评》20250321 《医药生物行业周报》20250310 《医药生物行业周报》20250304 医药生物 | 证券研究报告 — 行业点评 2025 年 5 月 9 日 强于大市 医药行业 24 年年报及 25 年 一季报综述 医药板块上市公司 24 年年报及 25 年一季报已经披露完毕，我们选取申万医药行业分类 （2021）作为统计板块，截至 2025 年 4 月 30 日，近 3 年申万医药行业成分股数量分别为 488、497、499 个。我们采用整体法对板块的营业收入、归母净利润、销售费用率等指标进 行统计。整体看，虽然 24 年及 25 年一季度行业仍然承压，但行业研发费用依然持续增加， 且集采、反腐对不少细分子板块如耗材、制药等影响已经逐步弱化，板块收入和利润均逐 步回暖，后续随着创新产品的不断落地，我们看好医药行业的长期发展，维持强大于市评级。 中银国际证券股份有限公司 具备证券投资咨询业务资格 医药生物 证券分析师：刘恩阳 enyang.li ...

资料来源：公司公告， Wind ，中银证券 以 2025 年 5 月 8 日收市价为标准 中银国际证券股份有限公司 具备证券投资咨询业务资格 有色金属：能源金属 有色金属 | 证券研究报告 — 调整盈利预测 2025 年 5 月 9 日 300618.SZ 增持 原评级：增持 市场价格:人民币 33.12 板块评级:强于大市 股价表现 (%) 今年 至今 1 个月 3 个月 12 个月 绝对 2.0 11.5 (3.6) 10.8 相对深圳成指 0.9 3.3 (0.0) 5.0 发行股数 (百万) 308.32 流通股 (百万) 271.32 总市值 (人民币 百万) 10,211.72 3 个月日均交易额 (人民币 百万) 460.75 主要股东 梁杰 16.00% (29%) (13%) 2% 18% 33% 49% May-24 Jun-24 Jul-24 Aug-24 Sep-24 Oct-24 Nov-24 Dec-24 Jan-25 Mar-25 Apr-25 May-25 寒锐钴业 深圳成指 铜钴产销同比增长，产品种类不断丰富 公司发布 2024年年报和 2025年一季报，分别实现归母净利润 ...

证券研究报告——晨会聚焦 2025 年 5 月 9 日 | 5 月金股组合 | | | --- | --- | | 股票代码 | 股票名称 | | 002352.SZ | 顺丰控股 | | 1519.HK | 极兔速递-W | | 603181.SH | 皇马科技 | | 300014.SZ | 亿纬锂能 | | 688198.SH | 佰仁医疗 | | 000524.SZ | 岭南控股 | | 600519.SH | 贵州茅台 | | 9660.HK | 地平线机器人-W | | 688519.SH | 南亚新材 | | 301236.SZ | 软通动力 | 中银晨会聚焦-20250509 ■重点关注 【固定收益】为外部经济降温做好准备*张鹏 肖成哲。央行同时宣布降准降 息，或为对冲关税对美国商品需求的抑制效应。 【电力设备】电力设备系列报告之一*武佳雄 李扬 顾真。随着全球新能源 装机比例提升以及算力等新型用电场景的不断涌现，对于电网的扩容升级提 出了更高的要求，电力设备有望直接受益。主电网方面，电力跨区域传输以 及新能源发电外送需求提升推动特高压建设，柔性直流技术有望提升渗透 率；配电网方面，国内配网改 ...

有色金属 | 证券研究报告 — 调整盈利预测 2025 年 5 月 9 日 603876.SH 增持 原评级：增持 市场价格:人民币 8.68 板块评级:强于大市 股价表现 (%) 今年 至今 1 个月 3 个月 12 个月 绝对 0.3 12.3 (1.8) (25.5) 相对上证综指 (2.4) 5.7 (3.3) (32.6) (32%) (23%) (15%) (6%) 3% 12% May-24 Jun-24 Jul-24 Aug-24 Sep-24 Oct-24 Nov-24 Dec-24 Jan-25 Mar-25 Apr-25 May-25 鼎胜新材 上证综指 | 发行股数 (百万) | 930.96 | | --- | --- | | 流通股 (百万) | 929.27 | | 总市值 (人民币 百万) | 8,080.71 | | 3 个月日均交易额 (人民币 百万) | 186.27 | | 主要股东 | | | 杭州鼎胜实业集团有限公司 | 27.15% | | 资料来源：公司公告， Wind ， | 中银证券 | Wind 以 2025 年 5 月 8 日收市价为标准 支撑评级的要点 ...

策略研究 | 证券研究报告 — 总量点评 2025 年 5 月 8 日 A 股 2024 年年报及 2025 年 一季报分析 科技制造仍是关注重点 全 A 非金融景气修复有亮点，但过程仍较为坎坷。 中银国际证券股份有限公司 具备证券投资咨询业务资格 策略研究 证券分析师：王君 (8610)66229061 jun.wang@bocichina.com 证券投资咨询业务证书编号：S1300519060003 证券分析师：徐亚 （8621）20328506 ya.xu@bocichina.com 证券投资咨询业务证书编号：S1300521070003 ◼ 2024 年年报业绩未能改善，2025 年一季报业绩明显改善，两期营收改善 偏慢。全部 A 股/非金融 2024 年报累计归母净利润（下或简称业绩/净利 润）同比增速分别为-2.3%/ -12.9%，较 2024Q3（-0.5%/ -7.2%）下降-1.8/- 5.7Pct。全部 A 股/非金融 2025Q1 累计业绩同比增速分别为 3.6%/4.2%， 较 2024 年年报（-2.3%/-12.9%）大幅提升 5.8/17.1Pct。全部 A 股/非金融 20 ...

Investment Rating - The report initiates coverage with a "Buy" rating for the company [5][3]. Core Insights - The company, Hehe Information, is a leading player in the C-end productivity software market, driven by AI and overseas expansion [3][8]. - The company has a strong user base and brand influence, with expectations for continued growth in both C-end and B-end business segments [8][16]. - Revenue and profit margins have shown consistent improvement, with a projected revenue growth rate of 24.2% for 2025 [21][5]. Summary by Sections Company Overview - Hehe Information specializes in AI text recognition and commercial big data, having developed popular apps like "CamScanner" and "CamCard" [8][16]. - The company has been operational since 2006, focusing on text recognition and image processing technologies [16]. Financial Performance - From 2018 to 2024, the company's revenue increased from 196 million RMB to 1.438 billion RMB, with a compound annual growth rate (CAGR) of 39.39% [21][24]. - The net profit turned from a loss of 79 million RMB in 2018 to a profit of 401 million RMB in 2024, with a gross margin improvement from 72.54% to 84.28% [21][24]. Business Segments - The company's main revenue sources are from intelligent text recognition and commercial big data services, with the former contributing 84.53% of total revenue in 2024 [22][30]. - The "CamScanner" app generated 982 million RMB in revenue, accounting for 68.31% of the intelligent recognition segment [22][30]. Market Position and Growth Potential - The global market for intelligent text recognition services is expected to grow from 12.56 billion USD in 2023 to 32.9 billion USD by 2030, with a CAGR of approximately 14.8% [43][46]. - The Chinese market for intelligent text recognition services is projected to grow at a CAGR of 16.5%, outpacing global growth rates [43][46]. Product Development and Innovation - The company is expanding its product offerings, including new educational software aimed at the C-end market, which may become a new growth driver [8][16]. - The company has established a strong foothold in the B-end market, serving over 130 Fortune 500 companies and implementing solutions across nearly 30 industries [8][16].

食品饮料 | 证券研究报告 — 调整盈利预测 2025 年 5 月 8 日 01579.HK 增持 原评级：增持 市场价格:港币 13.76 板块评级:强于大市 股价表现 (%) 今年 至今 1 个月 3 个月 12 个月 绝对 (5.9) 11.9 4.2 (19.2) 相对恒生指数 (21.5) (2.6) (3.1) (41.9) 发行股数 (百万) 1,036.70 流通股 (百万) 1,036.70 总市值 (港币 百万) 14,264.99 (33%) (20%) (6%) 8% 22% 35% May/24 Jun/24 Jul/24 Aug/24 Sep/24 Oct/24 Nov/24 Dec/24 Jan/25 Mar/25 Apr/25 May/25 颐海国际 恒生指数 3 个月日均交易额 (港币 百万) 82.83 主要股东 UBS Trustees (B.V.I.) Limited（%） 31.39 资料来源：公司公告， Wind ，中银证券 (8610)66229391 tianjiao.deng@bocichina.com 证券投资咨询业务证书编号：S1300519080002 ...